Thompson Thrift’s Josh Purvis Honored with 2025 Indianapolis Business Journal C-Suite of the Year Award

Thompson Thrift, a full-service real estate companyand one of the nation's leading multifamily developers, announced today that Josh Purvis, managing partner of Thompson Thrift Residential, has been selected as a recipient of the Indianapolis Business Journal's 2025 C-Suite of the Year Awards. Purvis was recognized at IBJ's annual awards ceremony on December 2, held at […]

Arax Partner Firms Named to Newsweek’s Top Financial Advisory Firms 2026

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Arax Investment Partners (“Arax” or the “Company”), a premier wealth management firm backed by RedBird Capital Partners (“RedBird”), is pleased to announce that partner firms Ashton Thomas and U.S. Capital Wealth have been awarded a five-star rating on Newsweek's list of Top Financial Advisory Firms 2026. Launched

Star Group, L.P. to Host Fiscal 2025 Fourth Quarter Webcast and Conference Call December 9, 2025

(NYSE:SGU), STAMFORD, Conn., Dec. 03, 2025 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE: SGU), a leading home energy distributor and services provider, today announced that it will release its fiscal 2025 fourth quarter results after the close of trading on December 8, 2025. Members of Star's management team will host a

Arrakis Therapeutics Presents Data Highlighting Progress of Oral RNA-targeted Small Molecule to Treat Myotonic Dystrophy Type 1 (DM1)

Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing defects and reversal of myotonia Oral administration of lead drug candidate results in broad biodistribution, including to the muscle and heart Company plans to file an IND with U.S. FDA in 2026 for an oral drug candidate

Ascent Solar Technologies Provides Leading Space Company with Thin-Film PV modules for Spacecraft Power Generation Testing in Cislunar Space

(NASDAQ:ASTI), THORNTON, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) — Ascent Solar Technologies (“Ascent”), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced that it recently provided test modules of its thin-film PV technology to a leading space company. The modules are currently being tested on their

Acronis #TeamUp Program Brings Agilitec IT to Resorts World Las Vegas for First-of-Its-Kind Cybersecurity Partnership

LAS VEGAS, Dec. 03, 2025 (GLOBE NEWSWIRE) — Acronis, a global leader in cybersecurity and data protection, is proud to announce its latest #TeamUp partnership with Resorts World Las Vegas, supported by Agilitec IT, a leading Managed Service Provider (MSP). This marks the first-ever #TeamUp collaboration in the “Sports Adjacent” category, highlighting Acronis' expansion beyond

Upexi to Participate in Upcoming December Investor Conferences

(NASDAQ:UPXI), TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (“Upexi” or the “Company”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that management will participate in the following December 2025 investor conferences. Details for each conference can be found below. The link to webcasted presentations can

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

(NASDAQ:APYX), CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion(R) and the AYON Body Contouring System(TM) (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

(NASDAQ:IXHL), MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IHL-42X, the Company's oral fixed-dose combination product candidate for the treatment of obstructive sleep apnea

Abacus Global Management Announces Upcoming Conference Participation

(NASDAQ:ABL),(NASDAQ:ABLLW), ORLANDO, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) — Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced its participation in the following upcoming investor conferences. The Company will participate in the Sidoti Year-End Virtual Investor Conference, being held December 10-11, 2025. Chief Executive

Scroll to Top